EU Policy. Biotech strategy launch, Newsletter

Biotech development
Biotech development Copyright AP
By Gerardo FortunaEuronews
Share this articleComments
Share this articleClose Button

This week's key events presented by senior health reporter Gerardo Fortuna

Key diary dates


Tuesday 19 March: European Parliament’s committee vote on the reform of EU pharmaceutical rules.

Wednesday 20 March: Presentation of the European Commission's first 'EU Biotech and Biomanufacturing Initiative’.

Tuesday 19-Friday 22 March: European Commission organises Digital Markets Act workshops with gatekeepers.

In spotlight

This Wednesday (20 March) the European Commission is expected to unveil a new ‘EU Biotech and Biomanufacturing Initiative’ .

Despite half-hearted attempts at regulatory simplification in the sector in the past, life science technologies are increasingly drawing attention from policymakers.

Last month Euronews first reported on the health component of this initiative based on a leaked draft document that highlighted a focus on the vibrant biopharmaceutical sector – responsible for providing breakthrough messenger RNA (mRNA) molecules playing an essential role in COVID-19 vaccines.

But biotech applications are not limited to the health sector, ranging from sustainable sourcing of advanced materials to climate-smart production and other components essential to a fossil-free and circular economy.

A 'blue' biotech is also emerging, with new research on aquatic organisms and microalgae fermentation ready for commercial exploitation – not to mention the potential of new genomic techniques (NGTs) for food production, already under discussion by EU lawmakers.

The main goals of this initiative will be to survey the status quo and track future challenges facing the biotech sector to orientate policy efforts in readiness for the next legislative mandate.

Some policy ideas are likely to be proffered, such as a one-stop shop to permit and authorise biotech manufacturing – while a controversial proposal for an R&I tax credit for biotech companies is rumoured to have been shelved for the moment.

This first dedicated attempt to address the sector won’t be the last, with economic security and strategic autonomy likely to be key buzzwords for the next commission.

Biotech is expected to be a new beat to keep a close eye on and it has already been listed as a critical technology for the continent, together with semiconductors and artificial intelligence.

The defence imperative dominating current commission thinking involves European independence from military aircraft to sourcing these critical new technologies.

Policy newsmakers

Policy newsmakers
Policy newsmakersEuronews

@Hahn                                                                                                                   @Wiewiórowski

Commission under data notice

The European Commission was ordered last week to bring its use of Microsoft 365 office programs in line with its own rulebook, after European Data Protection Supervisor (EDPS) Wojciech Wiewiórowski found following an investigation that the commission breached EU rules on transfers of personal data outside the EU. The commission now needs to suspend all data flows resulting from its use of Microsoft 365 to Microsoft and to its affiliates and sub-processors located in countries outside the EU/EEA that are not covered by a data transfer agreement. The commissioner responsible for admin, Johannes Hahn, will have to demonstrate compliance with the orders by 9 December 2024.

Policy Poll

Should profits generated by Russian state assets frozen in Europe be:

Kept in trust for Russia


Used to rebuild Ukraine

Used to arm Ukraine


Subscribe here to see the results of last week's poll and stay informed on the latest EU policy developments with our weekly newsletter, “The Policy Briefing”. Your weekly insight on European rulemaking, policy issues, key events, and data trends.

Data brief

EU carbon dioxide emissions

Million tonnes of CO2 emissions
Million tonnes of CO2 emissionsFlourish
Share this articleComments

You might also like

Exclusive: Commission eyes Biotech Act to boost bloc’s life science sector

Bloc mulls ‘pooled sovereignty’ to exploit bioscience's untapped potential

Commission forges plan for European biopharma leadership – leak